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Abstract
Background: We performed the first meta-analysis of clinical studies by investigating the effects of eye-movement
desensitization and reprocessing (EMDR) therapy on the symptoms of posttraumatic stress disorder (PTSD), depression,
anxiety, and subjective distress in PTSD patients treated during the past 2 decades.
Methods: We performed a quantitative meta-analysis on the findings of 26 randomized controlled trials of EMDR therapy for
PTSD published between 1991 and 2013, which were identified through the ISI Web of Science, Embase, Cochrane Library,
MEDLINE, PubMed, Scopus, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature electronic
databases, among which 22, 20, 16, and 11 of the studies assessed the effects of EMDR on the symptoms of PTSD,
depression, anxiety, and subjective distress, respectively, as the primary clinical outcome.
Results: The meta-analysis revealed that the EMDR treatments significantly reduced the symptoms of PTSD (g=20.662;
95% confidence interval (CI): 20.887 to 20.436), depression (g=20.643; 95% CI: 20.864 to 20.422), anxiety (g=20.640;
95% CI: 20.890 to 20.390), and subjective distress (g=20.956; 95% CI: 21.388 to 20.525) in PTSD patients.
Conclusion: This study confirmed that EMDR therapy significantly reduces the symptoms of PTSD, depression, anxiety, and
subjective distress in PTSD patients. The subgroup analysis indicated that a treatment duration of more than 60 min per
session was a major contributing factor in the amelioration of anxiety and depression, and that a therapist with experience
in conducting PTSD group therapy was a major contributing factor in the reduction of PTSD symptoms.
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Introduction
Eye movement desensitization and reprocessing (EMDR) was
developed by Francine Shapiro [1], and is a complex and specific
desensitizing treatment method. EMDR therapy desensitizes
patients to anxiety and integrates information processing [1].
Adaptive information processing is the theoretical framework for
EMDR, because it addresses factors related to both pathology and
personality development. Adaptive information processing con-
tributes to orienting responses (ORs), which involve retrieving
information from previous experiences and integrating them into a
positive emotional and cognitive schema [2]. A dual-attention
stimulus, such as eye movement, is an integral component of
EMDR because it induces certain physiological conditions that
activate information processing. Eye movements may unblock the
information-processing centers of the brain, creating a connection
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between stored information on previous events and adverse
outcomes that is used to generate a response to a current stimulus.
Subsequently aroused relaxation responses or a new series of
physiological responses reconnect to the stored information on
previous adverse experiences, and the new information is
reintegrated [2].
A meta-analysis was conducted by Davidson and Parker [3] to
analyze 34 controlled experimental studies that had examined the
effects of EMDR therapy on patients with anxiety disorders. Their
results indicated that EMDR therapy significantly reduced the
symptoms of anxiety disorders, with a Cohen’s d of 0.87 and a
95% confidence interval (CI) of 0.18 to 0.58 (p,0.01). Another
meta-analysis of controlled experimental studies conducted by
Rodenburg et al. [4] revealed that EMDR therapy significantly
reduced the symptoms of posttraumatic stress disorder (PTSD) in
children, with a Cohen’s d of 0.56 and a 95% CI of 0.42 to 0.70
(p,0.001).
A literature review reported that EMDR therapy significantly
reduced the symptoms of depression, thereby reducing the
Montgomery-Asberg Depression Rating Scale (MADRS), Hamil-
ton Depression Scale (HAM-D), and Beck Depression Inventory
(BDI) scores from 26.4 to 9.3, 29.5 to 26.8, and 25.95 to 10.70,
respectively [5–7]. Previous studies have indicated that EMDR
therapy significantly reduced the symptoms of anxiety, reducing
the Beck Anxiety Inventory (BAI) and State-Trait Anxiety
Inventory (STATE) scores from 33.8 to 16.2 and 51.10 to 32.60,
respectively, and similar studies of anxiety reported that EMDR
therapy reduced the Hamilton Anxiety Scale (HAM-A), Hospital
Anxiety and Depression Scale (HADS), and STATE scores from
26.2 to 9.1, 15.3 to 7.7, and 52.14 to 35.17, respectively, among
which one study reported a moderate effect size and a Cohen’s d
of 0.66 [6–9]. Other previous studies have indicated that EMDR
significantly improved the subjective distress index, with Cohen’s d
ranging from 1.04 to 2.07 and the mean subjective units of distress
(SUD) reduced from 7.02 to 2.72 [8,10–16].
Despite the wealth of information on the efficacy of EMDR for
treating PTSD, the magnitude of the effects of EMDR therapy on
anxiety, depression, and subjective distress in PTSD patients
remains largely unclear. We performed a quantitative meta-
analysis on the findings of various clinical studies reported between
1991 and 2013 that have investigated the effects of EMDR
therapy on the symptoms of PTSD, depression, anxiety, or
subjective distress in PTSD patients. Our results indicated that
EMDR therapy significantly reduced the symptoms of PTSD,
depression, anxiety, and subjective distress in PTSD patients, with
moderate to large effect sizes.
Materials and Methods
Reporting Standards
The current study was conceived, conducted, and reported
according to the Preferred Reporting Items for Systematic
Reviews and Meta-analyses (PRISMA) statement for meta-
analyses of randomized controlled trials (RCTs).
Search Strategy
This study included a quantitative investigation of studies
involving the use of EMDR for treating PTSD that were published
between January 1991 and December 2013, which were identified
using the ISI Web of Science, Embase, Cochrane Library,
MEDLINE, PubMed, SCOPUS, PsycINFO, and Cumulative
Index to Nursing and Allied Health Literature electronic
databases. Studies were identified through database searches
conducted using the medical subject headings (MeSHs) ‘‘eye
movement desensitization reprocessing’’ and ‘‘posttraumatic stress
disorder’’, or keyword searches using ‘‘PTSD’’ and ‘‘EMDR’’ or
‘‘eye movement desensitization.’’ The Web sites of professional
associations and the reference lists of relevant articles were
examined, and Internet searches were performed using the Google
Scholar search engine to identify additional studies that had not
yet been included in the aforementioned electronic databases.
Inclusion and Exclusion Criteria
The inclusion criteria for the current study were based on those
used in similar studies and our research objectives. Previous studies
were selected for the meta-analysis based on the following
inclusion criteria: (1) published between January 1991 and
December 2013; (2) included PTSD patients treated with EMDR;
(3) met the requirements of an RCT established by the Cochrane
Collaboration [17]; (4) EMDR was administered by trained
professionals, including physicians, nurses, or psychotherapists; (5)
control patients received other treatment or no treatment; and (6)
the assessment of clinical outcomes included an adequate statistical
analysis of the effect size, such as the mean, standard deviation,
mean difference, sample size, t value, F value, odds ratio (OR), or
P value. Duplicate publications, qualitative studies, quasi-experi-
mental studies, and single-subject or single-group experimental
studies were excluded. The RCT selection process is depicted in
Figure 1.
Outcome Measures
We considered various clinical outcomes that were reported in
the selected RCTs to demonstrate improvements in the symptoms
of PTSD, depression, anxiety, and subjective distress. PTSD
symptoms were assessed using the Clinician-Administered PTSD
Scale (CAPS), the PTSD Checklist (PCL-C), the Child Report of
Posttraumatic Symptoms (CROPS), the self-reported Symptom
Checklist of the Structured Interview for PTSD (SI-PTSD), and
the Impact of Event Scale (IES). Depression was assessed using the
HADS, MADRS, BDI, and HAM-D instruments. Anxiety was
assessed using the HAM-A, BAI, and STATE instruments.
Subjective distress was assessed based on the SUD instrument.
Data Extraction
Sample selection and variable interpretation are easily biased.
Therefore, Cohen’s k was used to evaluate the reliability between
raters and registrants to avoid bias associated with sample selection
or variable interpretation, with a value of k.0.65 indicating
acceptable consistency between raters and registrants [18]. A
doctoral student experienced in psychiatric studies and trained in
research methodology registered the clinical variables. The
investigator and the collaborative rater separately registered all
of the selected studies with regard to design, diagnosis, interven-
tion, interveners, and outcome variables, and both performed an
inter-rater reliability test, yielding a kappa value of 0.86. If
disagreements occurred between the two reviewers, a third
reviewer, a professor with experience performing meta-analyses,
reconciled the difference. We contacted several of the authors
directly and obtained clarification regarding data that were not
included in the published report. The results of the analysis of the
outcome measures of the selected studies are shown in Table 1.
Assessment of Methodological Quality
The methodological quality of the studies was assessed
independently by two reviewers. Eligible studies were assessed
for potential bias by using the method described by the Cochrane
Collaboration [17], which classified the studies as having a low,
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moderate, or high risk of bias across the following six domains:
sequence generation, allocation concealment, blinding, missing
data, selective reporting, and other biases. The research quality of
the study design, patients, outcome measures, statistical analysis,
and results of the selected RCTs were assessed using the approach
described by Brodaty, Green, and Koschera [19], according to the
guidelines established by the Cochrane Collaboration, with a total
research-quality score of six to ten indicating an acceptable level of
quality, and a score less than or equal to five indicating an
unacceptable level of quality. Twenty-six RCTs that received a
total research-quality score greater than six were included in the
meta-analysis. The k value for inter-rater reliability for the
research-quality assessment was 0.89.
Publication Bias and Sensitivity Analysis
Publication bias can influence the effect size of the outcome
measures examined in meta-analyses. Publication bias in our
meta-analysis was estimated using a funnel plot. An asymmetrical
funnel plot indicates that supplementation is required because of
missing studies [20]. The ORs reported in the selected RCTs were
subjected to Egger’s test [21], which uses linear regression on a
natural logarithmic scale to assess funnel plot asymmetry, with the
level of significance set at p,0.05. In addition, sensitivity analysis
was performed by comparing the pooled results from the selected
RCTs with those that excluded studies during selection.
Statistical Analysis
We used the Comprehensive Meta-Analysis, Version 2.0,
program for the statistical analysis. Hedges’s g was calculated to
determine the effect size [22], and Cohen’s d [23] was calculated
to obtain the overall effect size, with d values $0.8, 0.5 to 0.7, and
0.2 to 0.4 representing large, moderate, and small effect sizes,
respectively. The heterogeneity among studies was determined
using an x2-based Q test, with a P value.0.05 indicating a lack of
heterogeneity among studies. Heterogeneity among the studies
was also assessed by calculating the I2 statistic, with I2 values of
Figure 1. PRISMA 2009 flow diagram.
doi:10.1371/journal.pone.0103676.g001
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Table 1. Characteristics of EMDR for patients with PTSD of the randomized controlled trials (RCTs) included in the meta-analysis
(N= 26).
Study Intervention Design
Sample size
(patients)
Intervention
characterization Outcome
Study
quality/
(Experimental/Control)
Cochrane
tool
Vaughan et al.
(1994)
EMD/AMR RCT Total N: 36 Number of times
treated: 4
self-rating scales 8
Complete N
(T/C): 12/11
Treatment duration
(min): 50
Anxiety (SYAI) AA:low
Mean age
(yr): 32
Each group size
(people): individual
Depression (BDI) AC:unclear
EMDR therapist: - non-self-rating scales BAO:low
PTSD group
experience: undisclosed
Symptoms (SI-PTSD) IO:low
Depression (HRSD) SRO:low
Jensen (1994) MDR/delayed MDR RCT Total N: 25 Number of times
treated: 3
self-rating scales 6/
Complete
N (T/C): 13/12
Treatment
duration (min): -
SUD AA:low
Mean age
(yr): 43.1
Each group size
(people): individual
non-self-rating scales AC:unclear
EMDR therapist: - Symptoms (SI-PTSD) BAO:unclear
PTSD group
experience: yes
IO:high
SRO:low
Wilson et al.
(1995)
EMDR/delayed MDR RCT Total N: 80 Number of times
treated: 3
self-rating scales 8/
Complete
N (T/C): -/-
Treatment duration
(min): 90
Symptoms (IES) AA:low
Mean age
(yr): 39
Each group size
(people): individual
Anxiety (STAI-state/trait) AC:unclear
EMDR therapist:
certified professional
Depression (SCL-R-D) BAO:unclear
PTSD group
experience: yes
IO:unclear
SRO:low
Dunn et al.
(1996)
EMDR/visual placebo RCT Total N: 28 Number of times
treated: -
self-rating scales 6/
Complete
N (T/C): -/-
Treatment duration
(min): -
SUD AA:low
Mean age
(yr):-
Each group size
(people): individual
AC:unclear
EMDR therapist:
certified professional
BAO:unclear
PTSD group
experience: yes
IO:low
SRO:low
Rothbaum
(1997)
EMDR/WL RCT Total N: 18 Number of times
treated: 3
self-rating scales 7/
Complete N
(T/C): 10/8
Treatment duration
(min): 90
Symptoms (IES) AA:low
Mean age
(yr): 34.6
Each group size
(people): individual
Depression (BDI) AC:unclear
EMDR therapist:
certified professional
Anxiety (STAI-state/trait) BAO:low
PTSD group
experience: yes
non-self-rating scales IO:high
Symptoms(PTSD-symptoms, PSS) SRO:low
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Table 1. Cont.
Study Intervention Design
Sample size
(patients)
Intervention
characterization Outcome
Study
quality/
(Experimental/Control)
Cochrane
tool
Marcus et al.
(1997)
EMDR/SC RCT Total N: 67 Number of times
treated: 3
self-rating scales 7/
Complete N
(T/C): -/-
Treatment duration
(min): 50
Symptoms (Modified PTSD scale) AA:low
Mean age
(yr): 42.4
Each group size (people):
individual
Symptoms (IES) AC:unclear
EMDR therapist: nil Anxiety (STAI-state/trait) BAO:low
PTSD group
experience: yes
SUD IO:unclear
SRO:low
Devilly et al.
(1998)
EMDR/SPS RCT Total N: 51 Number of times
treated: 2
self-rating scales 8/
Complete N
(T/C): 20/10
Treatment duration
(min): 90
Symptoms (M-PTSD) AA:low
Mean age
(yr): 50.1
Each group size (people):
individual
Anxiety (STAI-Y2) AC:unclear
EMDR therapist: certified
professional
SUD BAO:unclear
PTSD group
experience: yes
IO:high
SRO:low
Scheck et al.
(1998)
EMDR/AL RCT Total N: 60 Number of times
treated: 2
self-rating scales 7/
Complete N
(T/C): 30/30
Treatment duration
(min): 90
Symptoms (IES) (PENN) AA:low
Mean age
(yr): 20.9
Each group size (people):
individual
Depression (BDI) AC:low
EMDR therapist: certified
professional
Anxiety (STAI-state) BAO:low
PTSD group
experience: yes
IO:high
SRO:low
Carlson et al.
(1998)
EMDR/routine clinical care RCT Total N: 35 Number of times
treated: 12
self-rating scales 8/
Complete N
(T/C): 10/12
Treatment duration
(min): 60,75
Symptoms (PTSD-symptoms) AA:low
Mean age
(yr): 48.3
Each group size (people):
individual
Symptoms (IES) AC:unclear
EMDR therapist: nil Anxiety(STAI-state/trait) BAO:low
PTSD group
experience: yes
Depression (BDI) IO:low
SRO:low
Rogers et al.
(1999)
EMDR/exposure RCT Total N: 12 Number of times
treated: 1
self-rating scales 6/
Complete N
(T/C): 6/6
Treatment duration
(min): 60,90
Symptoms (IES) AA:low
Each group size (people):
individual
SUD AC:unclear
Mean age
(yr): 47,53
EMDR therapist: - BAO:low
PTSD group
experience: yes
IO:low
SRO:low
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Table 1. Cont.
Study Intervention Design
Sample size
(patients)
Intervention
characterization Outcome
Study
quality/
(Experimental/Control)
Cochrane
tool
Devilly &
Spence (1999)
EMDR/TTP RCT Total N: 23 Number of times treated: 8 self-rating scales 7/
Complete N
(T/C): 11/12
Treatment duration (min):
90,120
Symptoms (IES) (PSS-SR) AA:low
Mean age
(yr): 38
Each group size (people):
individual
Anxiety (STAI-trait) AC:unclear
EMDR therapist: - Depression (BDI) BAO:unclear
PTSD group
experience: yes
IO:low
SRO:low
Wilson et al.
(2001)
EMDR/SMP RCT Total N: 62 Number of times
treated: 3
self-rating scales 7/
Complete N
(T/C): 33/29
Treatment duration
(min): -
SUD AA:low
Mean age
(yr): 36.8
Each group size (people):
individual
non-self-rating scales AC:unclear
EMDR therapist: - Symptom (PTSD-symptoms) BAO:low
PTSD group experience:
disclosed
IO:high
SRO:low
Power et al.
(2002)
EMDR/WL RCT Total N: 72 Number of times treated: 1 self-rating scales 8/
Complete
N(T/C): 27/24
Treatment duration
(min): 90
Symptoms (IOS) AAA:low
Mean age
(yr): 39.4
Each group size
(people): individual
Symptoms (SI-PTSD) AC:unclear
EMDR therapist:
certified professional
Depression (HADS-D) BAO:low
PTSD group
experience: yes
Anxiety (HADS-A) IO:high
SRO:low
Ironson et al.
(2002)
EMDR/PE RCT Total N: 22 Number of times
treated: 6
self-rating scales 7/
Complete
N(T/C): 10/12
Treatment duration
(min): 90
Symptoms (PSS-SR) AA:low
Mean age
(yr): 16,62
Each group size
(people): individual
Depression (BDI) AC:unclear
EMDR therapist:
certified professional
SUD BAO:high
PTSD group
experience: yes
IO:high
SRO:low
Chemtob et al.
(2002)
EMDR/WL RCT Total N: 32 Number of times
treated: 3
self-rating scales 7/
Complete
N(T/C): 17/15
Treatment duration
(min): -
Depression (CDI) AA:low
Mean age
(yr): 8.4
Each group size
(people): individual
Anxiety (RCMAS) AC:unclear
EMDR therapist:
certified professional
non-self-rating scales BAO:unclear
PTSD group
experience: yes
Symptoms (CRI) IO:low
SRO:low
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Table 1. Cont.
Study Intervention Design
Sample size
(patients)
Intervention
characterization Outcome
Study
quality/
(Experimental/Control)
Cochrane
tool
Lee et al.
(2002)
EMDR/SITPE RCT Total N: 24 Number of times
treated: 7
self-rating scales 6/
Complete
N(T/C): 12/12
Treatment duration
(min): 90
Symptoms (IES) AA:low
Mean age
(yr): 35.3
Each group size
(people): individual
Depression (BDI) AC:unclear
EMDR therapist:
certified professional
non-self-rating scales BAO:high
PTSD group
experience: yes
Symptoms (SI-PTSD) IO:high
SRO:low
Lytle et al.
(2002)
EMDR/non-direct therapy RCT Total N: 45 Number of times
treated: 1
self-rating scales 7/
Complete
N(T/C): 15/15
Treatment duration
(min): 60
Symptoms (IES) AA:low
Mean age
(yr): 18.95
Each group size
(people): individual
Depression (BDI) AC:unclear
EMDR therapist: - Anxiety (STAI-trait) BAO:unclear
PTSD group
experience: yes
IO:low
SRO:low
Taylor et al.
(2003)
EMDR/relaxation training RCT Total N: 60 Number of times
treated: 8
self-rating scales 7/
Complete
N(T/C): 19/19
Treatment duration
(min): 90
Depression (BDI) AA:low
Mean age
(yr): 37
Each group size
(people): individual
non-self-rating scales AC:unclear
EMDR therapist:
certified professional
Symptoms (CAPS) BAO:low
PTSD group
experience: yes
IO:low
SRO:low
Jaberghaderi
et al. (2004)
EMDR/CBT RCT Total N: 62 Number of times
treated: 12
self-rating scales 6/
Complete
N (T/C): 60/60
Treatment duration
(min): 30,45
Symptoms (CROPS) AA:low
Mean age (
yr): 12,13
Each group size
(people): individual
AC:unclear
EMDR therapist:
certified professional
BAO:low
PTSD group
experience: yes
IO:low
SRO:low
Rothbaum
et al. (2005)
EMDR/WL RCT Total N: 60 Number of times
treated: 9
self-rating scales 8/
Complete
N (T/C): 20/20
Treatment duration
(min): 90
Depression (BDI) AA:low
Mean age
(yr): 33.8
Each group size
(people): individual
Symptoms (IES) AC:unclear
EMDR therapist: - Anxiety (STAI-state/trait) BAO:unclear
PTSD group
experience: disclosed
IO:low
SRO:low
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Table 1. Cont.
Study Intervention Design
Sample size
(patients)
Intervention
characterization Outcome
Study
quality/
(Experimental/Control)
Cochrane
tool
Van der Kolk
et al. (2007)
EMDR/placebo RCT Total N: 88 Number of times
treated: 6
self-rating scales 7/
Complete N
(T/C): 29/29
Treatment duration
(min): 90
Depression (BDI-II) AA:low
Mean age
(yr): 36.1
Each group size
(people): individual
non-self-rating scales AC:unclear
EMDR therapist:
certified professional
Symptoms (CAPS) BAO:low
PTSD group
experience: yes
IO:low
SRO:low
Hogberg et al.
(2007)
EMDR/WL RCT Total N: 24 Number of times
treated: 5
self-rating scales 6/
Complete
N (T/C): 13/11
Treatment duration
(min): 90
Symptoms (IES) AA:low
Mean age
(yr): 43
Each group size
(people): individual
Anxiety (BAI) AC:low
EMDR therapist:
certified professional
non-self-rating scales BAO:unclear
PTSD group
experience: yes
Anxiety (HAMA-A) IO:low
Depression (HAMA-D) SRO:low
Ahmad et al. (2007) EMDR/WL RCT Total N: 33 Number of times
treated: 8
non-self-rating scales 7/
Complete
N (T/C): 17/16
Treatment duration
(min): 45
Symptoms (PTSS-C) AA:low
Mean age
(yr): 9.95
Each group size
(people): individual
AC:unclear
EMDR therapist: - BAO:low
PTSD group
experience: disclosed
IO:low
SRO:low
Abbasnejad
et al. (2007)
EMDR/WL RCT Total N: 41 Number of times
treated: 4
self-rating scales 7/
Complete
N (T/C): 21/20
Treatment duration
(min): 90
Depression (BDI) AA:low
Mean age
(yr): -
Each group size
(people): individual
Anxiety (BAI) AC:unclear
EMDR therapist: nil SUD BAO:unclear
PTSD group
experience: yes
IO:low
SRO:low
Kemp et al.
(2009)
EMDR/WL RCT Total N: 27 Number of times
treated: 4
self-rating scales 7/
Complete
N (T/C): 13/14
Treatment duration
(min): 60
Depression (CDS) AA:low
Mean age
(yr): 8.93
Each group size
(people): individual
SUD AC:unclear
EMDR therapist:
certified professional
non-self-rating scales BAO:unclear
PTSD group
experience: yes
Symptoms (Child PTS-RI) IO:high
SRO:low
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75%, 50%, 25%, and 0% indicating high, moderate, low, and no
heterogeneity, respectively [24]. The heterogeneity data were
evaluated using a random-effects model because it accommodated
the possibility that the underlying effect differed across studies.
The random-effects model is more conservative and has a wider
95% CI than a fixed-effects model.
Additional Analyses
Meta-regression analysis was performed to clarify the sources of
heterogeneity among the selected studies, and examine the
impacts of the various exclusion criteria on the overall results.
The Stata, Version 11, program (StataCorp, College Station, TX,
USA) was used to perform the meta-regression analysis based on a
random-effects model to determine the inherent inter-study
heterogeneity in sample size, treatment duration, number of
treatment sessions, year of publication, and participant character-
istics, such as mean age. To understand the influence of the
EMDR characteristics on the effect size and categorical variables,
we used subgroup analysis to identify characteristics that led to
prominent outcomes. Variables were examined using a mixed-
effects model that was based on both the fixed-effects and random-
effects models. Subgroup analysis was performed to determine any
potential moderating variables with regard to the effect size. In the
subgroup analysis, the categorical variables were evaluated using
the Comprehensive Meta-Analysis, Version 2, and program. The
results of group comparisons with a significant QB indicated the
potential effects of a moderator variable.
Results
Literature Search
As shown in Figure 1, we initially identified 1075 research
reports using the search strategy. Based on the content of the title
and abstracts, 333 articles were selected for further review. Among
them, 304 were excluded because they described quasi-experi-
mental studies, systematic reviews, or meta-analyses; provided no
quantitative data; or used control groups that received active
therapy. Of the remaining 29 RCTs, three were excluded because
they were duplicate studies or involved the use of inadequate
statistical analysis. The remaining 26 RCTs were included in our
meta-analysis.
Characteristics of Eligible Studies
Among the 26 RCTs selected for our study, 22, 20, 16, and 11
studies assessed the symptoms of PTSD, depression, anxiety, and
subjective distress, respectively, as the primary outcome. The
average age of the patients ranged from 12 to 63 years. The
research-quality scores ranged from 6 to 8. Regarding the
intervention, most of the studies used a manual (24 of 26), and
most of them used theories (22 of 26). Most of the therapists were
psychologists (14 of 26), or had group therapy experience (21 of 26;
Table 1).
Quality Assessment
The quality of the studies varied. The sequence allocation was
adequate in 26 studies. Two studies [5,9] reported allocation
concealment by an independent third party. Thirteen studies
[6,9,14,15,16,25,26,30,32,34,35,41,42] involved the use of blinded
outcome assessors, whereas 13 studies [5,7,8,10,12,13,27,28,31,37,
38,39,40] did not report blinding. Data completeness was
Table 1. Cont.
Study Intervention Design
Sample size
(patients)
Intervention
characterization Outcome
Study
quality/
(Experimental/Control)
Cochrane
tool
Karatzias
et al. (2011)
EMDR/EFT RCT Total N: 46 Number of times
treated: 8
self-rating scales 8/
Complete
N (T/C): 23/23
Treatment duration
(min): 60
Symptoms (PCL-C) AA:low
Mean age
(yr): 40.6
Each group size
(people): individual
Depression (HADS-D) AC:unclear
EMDR therapist: - Anxiety (HADS-A) BAO:low
PTSD group
experience: disclosed
non-self-rating scales IO:high
Symptoms (CAPS) SRO:low
Instruments: M-PTSD = Mississippi scale for combat-related PTSD; IES = Impact of Event Scale; SI-PTSD = Davidson’s Structured Interview for PTSD; PSS-SR = PTSD
Symptom Scale, Self-Report; CAPS = Clinician-Administered PTSD Scale; PCL-C = PTSD Checklist; SR = self-report; Child PTS-RI = Child Posttraumatic Stress Reaction
Index; CROPS = Child Report of Posttraumatic Symptoms; PENN = Penn Inventory for Posttraumatic Stress Disorder; CRI = Children’s Reaction Inventory; PTSS-C =
Posttraumatic Stress Symptom Scale for Children; HRSD = The 17-item Hamilton Rating Scale for Depression; BDI = Beck Depression Inventory; HADS-A = the Hospital
Anxiety and Depression Scale –Anxiety; HADS-D = the Hospital Anxiety and Depression Scale – Depression; MADRS = The Montgomery–A˚sberg Depression Rating
Scale; CDI = The Children’s Depression Inventory; HAMA-A = the Hospital Anxiety and Hamilton Anxiety Scale–Anxiety; HAMA-D = the Hospital Anxiety and Hamilton
Anxiety Scale–Depression; CDS = Children’s Depression Scale; BAI = Beck Anxiety Inventory; STAI = State-Trait Anxiety Inventory.
Intervention: AEM = automated EMD; AVA = active visual attention; IHT = image habituation training; AMR = applied muscle relaxation; REDDR = EMDR treatment
minus the eye movements; SPS = standard psychiatric support; AL = active listening; E + CR = exposure combined with cognitive restructuring; PE = prolonged
exposure; SITPE = stress inoculation training with prolonged exposure; EFD = eye fixation desensitization; CBT = cognitive behavioral therapy; EFT = emotional
freedom techniques; SC = standard care; WL = : waiting list; TTP = trauma treatment protocol; SMP = a standard stress management program.
Patients/Group characterization: T/C = treatment group/control group.
Cochrane tool: AA = adequacy of sequence allocation; AC = allocation concealment; BAO = blinding of assessors and outcomes; IO = incomplete outcome data; SRO
= selective reporting and other biases.
doi:10.1371/journal.pone.0103676.t001
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Figure 2. Overall effect size of the reduction in the symptoms of PTSD following EMDR therapy (n=22 studies).
doi:10.1371/journal.pone.0103676.g002
Figure 3. Overall effect size of the reduction in the symptoms of depression in PTSD patients following EMDR therapy (n=20
studies).
doi:10.1371/journal.pone.0103676.g003
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addressed in most of the studies. Adequate assessments of each
outcome and adequate selective outcome reporting were per-
formed in all of the RCTs. Intention-to-treat analyses were
conducted in three studies [7,25,32]. Research-quality scores of
eight, seven, and six were determined for seven, twelve, and six
studies, respectively.
Publication Bias and Sensitivity Analyses
In the analysis of publication bias, the funnel plot did not appear
asymmetrical, and the Egger’s regression analysis of the funnel plot
indicated that it was statistically symmetrical (data not shown),
suggesting that publication bias did not influence our results.
Sensitivity analyses were performed to assess the influence of each
individual study on the pooled effect size (Hedges’s g) based on the
systematic omission of individual studies from our meta-analysis.
Efficacy Analysis
The effect sizes of the selected studies were significant for
symptoms of PTSD, depression, anxiety, and subjective distress.
The data revealed that EMDR group therapy resulted in
significant improvement in patients with PTSD (Table 2). The
Hedges’s g of the 22 studies that examined PTSD symptoms
following EMDR therapy was 20.662, and the 95% CI was 2
0.887 to 20.436 (Table 2; Figure 2). The effect sizes for sample
collection were all negative, with Hedges’s g ranging from 20.101
to 22.416. The meta-analysis revealed that the overall reduction
in PTSD symptoms following EMDR therapy was significant, with
a moderate effect size. Substantial heterogeneity was observed
among the studies in which PTSD symptoms were the outcomes
measured (Q=65.062, p=0.001, I2=67.723). The funnel plot for
these studies was approximately symmetrical, and the Egger’s
regression test revealed no publication bias (p=0.98). The
sensitivity analysis indicated that the removal of any one study
did not affect the overall results.
Twenty studies that investigated depression as the primary
outcome following EMDR therapy were included in our meta-
analysis. The Hedges’s g for the overall effect size was20.643, and
the 95% CI was 20.864 to 20.422 (Table 2, Figure 3). The effect
sizes for sample collection were all negative, with the Hedges’s g
ranging from 20.076 to 21.995. These results suggested that the
overall reduction in depression following EMDR therapy was
significant, with a moderate effect size. Heterogeneity among the
studies of depression was moderate (Q=42.657, p=0.001,
I2=55.458). The funnel plot for these studies was approximately
symmetrical, and the Egger’s regression test revealed no publica-
tion bias (p=0.74). The sensitivity analysis indicated that the
removal of any one study did not affect the overall results.
Sixteen studies that examined anxiety as the primary outcome
following EMDR therapy were included in our meta-analysis. The
Hedges’s g of the overall effect size was 20.640, with a 95% CI of
20.890 to 20.390 (Table 2; Figure 4). The effect sizes for sample
collection were all negative, with Hedges’s g ranging from 20.031
to 22.039. The results indicated that the overall reduction in
anxiety following EMDR therapy was significant, with a moderate
effect size. Substantial heterogeneity was observed among the
anxiety studies (Q=46.804, p=0.001, I2=67.951). The funnel
plot for these studies was approximately symmetrical, and Egger’s
regression test revealed no publication bias (p=0.96). The
sensitivity analysis indicated that the removal of any one study
did not affect the overall results.
Twelve studies that examined subjective distress as the primary
outcome were included in our meta-analysis. The Hedges’s g for
overall effect size was 20.956, with a 95% CI of 21.388 to 2
0.525 (Table 2; Figure 5). The effect sizes for sample collection
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were all negative, with Hedges’s g ranging from 20.227 to 2
2.243. These results indicated that the overall improvement in
subjective distress following EMDR therapy was significant, with a
large effect size. Heterogeneity among the studies of subjective
distress was moderate to high (Q=47.622, p=0.001, I2=76.901).
The funnel plot for these studies was approximately symmetrical,
and the Egger’s regression test revealed no publication bias
Figure 4. Overall effect size of the reduction in the symptoms of anxiety in PTSD patients following EMDR therapy (n=16 studies).
doi:10.1371/journal.pone.0103676.g004
Figure 5. Overall effect size of the reduction in the symptoms of subjective distress in PTSD patients following EMDR therapy
(n=12 studies).
doi:10.1371/journal.pone.0103676.g005
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(p=0.93). The sensitivity analysis indicated that the removal of
any one study did not affect the overall results.
Subgroup Analyses of Posttraumatic-Stress Disorder,
Depression, Anxiety, and Subjective Distress
The subgroup analysis of the improvement index for PTSD
symptoms revealed that the effect size for the group led by a
therapist with experience in PTSD group therapy (g=20.753)
was significantly larger (QB=7.195; p=0.007) than that of the
group led by a therapist without such experience (g=20.234;
Table 3). The subgroup analysis of the depression improvement
index indicated that the effect size of a treatment duration of .
60 min per session (g=20.811) was significantly larger
(QB=7.345; p=0.007) than that of a treatment duration of #
60 min per session (g=20.295; Table 3). The subgroup analysis
of the anxiety improvement index revealed that the effect size for a
treatment duration .60 min per session (g=20.860) was
significantly larger (QB=6.191; p=0.045) than that for a
treatment duration #60 min per session (g=20.351; Table 4).
The subgroup analysis of the subjective distress improvement
index suggested homogeneity in a majority of the studies, with only
one study remaining after stratification. Thus, heterogeneity
among the subjective distress studies did not appear to have
influenced our results (Table 4).
Meta-Regression Analyses
The meta-analyses of the RCTs conducted to investigate the
effects of EMDR on the symptoms of PTSD, depression, anxiety,
and subjective distress in PTSD patients were performed using
unrestricted maximum-likelihood meta-regressions. No significant
relationship was observed between the effect size for PTSD and
participant age (b=20.01, t=20.69), publication year (b=0.02,
t=1.00), sample size (b=20.01, t=20.41), the number of
treatment sessions (b=0.03, t=1.02), or treatment duration
(b=20.01, t=21.10). No significant relationship was observed
between the effect size for depression and participant age (b=2
0.02, t=21.78), publication year (b=0.01, t=0.98), sample size
(b=20.01, t=20.43), number of treatment sessions (b=20.01,
t=20.13), or treatment duration (b=20.01, t=21.45). No
significant relationship was observed between the effect size for
anxiety and participant age (b=20.01, t=21.37), publication
year (b=0.01, t=0.10), sample size (b=20.01, t=21.35),
number of treatment sessions (b=20.01, t=20.10), or treatment
duration (b=20.01, t=21.45). No significant relationship was
observed between the effect size for subjective distress and
participant age (b=0.03, t=1.38), publication year (b=20.08,
t=21.53), sample size (b=20.01, t=20.81), number of treat-
ment sessions (b=0.06, t=0.23), or treatment duration (b=0.01,
t=0.34).
Discussion
Main Findings
The objective of the current study was to perform meta-analysis
on previously reported RCTs to determine the magnitude of the
effects of EMDR therapy on the symptoms of PTSD, depression,
anxiety, and subjective distress in patients with PTSD. The meta-
analysis revealed that the effect sizes for EMDR therapy for
PTSD, depression, and anxiety were moderate, whereas the effect
size for EMDR therapy for subjective distress was large. These
results suggest that EMDR therapy can improve self-awareness in
patients, change their beliefs and behaviors, reduce anxiety and
depression, and lead to positive emotions.
PTSD patients cannot properly manage their negative experi-
ences or memories. EMDR therapy involves the use of eye
movements to induce ORs, and enables PTSD patients to create
adaptive connections to integrate negative experiences with
positive emotions and cognitions, thereby significantly improving
PTSD symptoms. Our findings were similar to those of Davidson
and Parker [3], who conducted a meta-analysis on quantitative
studies of EMDR therapy published between 1988 and 2000.
They reported a moderate effect size for EMDR therapy (r=0.40,
Cohen’s d=0.87), compared with that of other non-specified
therapies. Other studies have reported that EMDR therapy
produced increased reductions in PTSD symptoms, compared
with that produced by medication therapy and control groups
[6,32].
Depression is often comorbid with PTSD [33]. Twenty of the
26 studies included in our meta-analysis indicated that EMDR
therapy significantly reduced the symptoms of depression in
patients with PTSD, and our analysis revealed a moderate effect
size for EMDR therapy for depression. Our findings are consistent
with those of other studies on depression, which have demon-
strated that EMDR group therapy significantly reduced the
symptoms of depression, compared with control groups
[5,7,12,30].
Specific traumatic stressors cause PTSD patients to experience
anxiety when coping with stress. Sixteen of the 26 studies included
in our meta-analysis reported that EMDR therapy significantly
reduced anxiety in PTSD patients, and our analysis revealed a
moderate effect size for EMDR therapy for anxiety. Our findings
are consistent with those of Scheck et al. [9], who reported that
EMDR therapy significantly reduced anxiety in women with
PTSD, with a moderate effect size (Cohen’s d=0.66). Our
findings are also consistent with those of Abbasnejad et al. [8] and
Power et al. [6], which indicated that EMDR therapy significantly
reduced the symptoms of anxiety in patients, compared with those
experienced by control patients awaiting treatment. EMDR
therapy relieves anxiety by reprocessing information when PTSD
patients undergo a subsequent traumatic event.
Patients with PTSD experience subjective distress because they
have been disturbed by previous negative experiences, and wish to
avoid the memories of those experiences. Our meta-analysis of 12
studies on the effects of EMDR therapy on subjective distress
revealed that the effect size was large. Wilson et al. [16] examined
the effects of EMDR therapy on 62 police officers who had
experienced traumatic events, and their results indicated that
EMDR therapy significantly reduced subjective distress, with a
large effect size (Cohen’s d=2.07). Our findings are consistent
with those of a meta-analysis conducted by Davidson and Parker
in 2001 [3], which included quantitative studies related to EMDR
therapy published between 1988 and 2000. They reported that
EMDR therapy reduced subjective distress, with a large effect size
(r=0.81, Cohen’s d=2.71). Kemp et al. [12] also demonstrated
that, compared with a control group awaiting treatment,
subjective distress was significantly reduced in patients who had
undergone EMDR therapy. Thus, EMDR therapy reduces
anxiety and subjective distress when patients undergo a subsequent
traumatic event.
Subgroup Findings
We performed subgroup analysis based on the characteristics of
the therapist, the intervention, and the study design and
methodology. Treatment duration per session was the principal
characteristic of the intervention. Our subgroup analysis indicated
that a treatment duration of .60 min per session was more
effective than shorter treatment durations, which significantly
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reduced both anxiety and depression. Previous studies on EMDR
therapy involving the use of interventions ranging from 50 to
120 min in duration have reported reduced PTSD symptoms, but
the levels of improvement were inconsistent [12,13,16,30,34,35],
suggesting that a potential moderator influenced the effects of
EMDR therapy. Nonetheless, these findings are consistent with
those of our meta-analysis, which revealed that a treatment
duration of .60 min per session reduced anxiety and depression
in patients with PTSD.
We discovered that patients exhibited greater reductions in
PTSD symptoms when they received EMDR therapy from
therapists experienced in PTSD-group therapy, compared with
those treated by therapists without such experience. This subgroup
analysis result also reflects the benefits of EMDR therapy for
PTSD patients. These findings are generally consistent with those
of previous studies [29,36], which have reported that patients
exhibited greater reductions in the symptoms of depression
following cognitive therapy when treated by a therapist experi-
enced in group therapy, compared with those treated by therapists
without group-therapy experience.
Limitations
The major limitation of the present study is that considerable
variations were observed in the study designs, outcome measure-
ment scales, and sample sizes of the various RCTs included in our
meta-analysis, which affected the overall effect size and the results
of the overall subgroup analysis. The accuracy of the effect size
estimation also affected the meta-analysis results. Furthermore, the
methods of data collection were inconsistent among the various
RCTs selected, and the details of data collection were provided
only in studies in which intention-to-treat analyses were per-
formed, which might have led to an overestimation of the effect
size. By contrast, missing baseline values might have led to an
underestimation of the effect size.
Implications
Our meta-analysis of RCTs revealed that EMDR may be
helpful for treating PTSD and depression, anxiety, and subjective
distress in PTSD patients. We determined that therapists
experienced in PTSD group therapy and a duration of treatment
.60 min per session also contributed to reductions in the
symptoms of PTSD, depression, anxiety, and subjective distress
in PTSD patients following EMDR therapy. In addition, the effect
sizes determined in our meta-analysis support EMDR as the
optimal type of psychotherapy for PTSD patients.
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